Monsanto Licenses CRISPR/Cpf1 From Broad Institute | GenomeWeb

NEW YORK (GenomeWeb) – Agricultural giant Monsanto has licensed CRISPR/Cpf1 genome editing technology from the Broad Institute.

Under the terms of the agreement, Monsanto gains worldwide, non-exclusive rights to agricultural applications of the CRISPR/Cpf1 system.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.